Skip to content

Net margin at other companies

Biogen logo
BiogenBIIB
14.3%-0.8pp
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
21.6%+8.9pp
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
37.1%+0.2pp
PTC Therapeutics logo
PTC TherapeuticsPTCT
42.3%+27.4pp
BridgeBio Pharma logo
BridgeBio PharmaBBIO
-125.9%-54.5pp
TG Therapeutics logo
TG TherapeuticsTGTX
66%+55.8pp

Other financials

Income statement

See full
Revenue$268.1M+9.7%
Gross profit$243.3M+8.6%
Operating income-$4.6M-124%
Net income$3.6M-80.8%
EPS (diluted)$0.02-81.8%

Balance sheet

See full
Cash & equivalents$282.2M+29.6%
Total debt$50.8M-9.3%
Total equity$1.2B+63.1%
Total assets$1.6B+41.8%

Cash flow

See full
Operating cash flow$34.0M+67.2%
CapEx$5.2M
Free cash flow$28.8M+41.6%

Valuation

See full
Market cap$3.7B+37.0%
Enterprise value$3.47B+36.6%
P/E9.9×-2.0×
P/S3.4×+0.7×

Profitability

See full
Gross margin91.5%-0.6pp
Operating margin7.4%-16.2pp
FCF margin18.9%

Returns & leverage

See full
Return on equity37.3%+0.1pp
Debt / equity0.0×
Current ratio3.6×+0.7×

Where this comes from

Calculated from Acadia Pharmaceuticals’s reported figures.

Based on trailing twelve months.

The official record: Acadia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Acadia Pharmaceuticals's net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Acadia Pharmaceuticals's net margin?
Acadia Pharmaceuticals (ACAD) reported net margin of 34.3% in Q1 2026.
How has Acadia Pharmaceuticals's net margin changed year-over-year?
Acadia Pharmaceuticals's net margin increased by 49.3% year-over-year, from 23% to 34.3%.
What is the long-term trend for Acadia Pharmaceuticals's net margin?
Over 5 years (2020 to 2025), Acadia Pharmaceuticals's net margin has grown at a -10.6% compound annual growth rate (CAGR), from -63.7% to 36.5%.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.